Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Hou

Showing results (811-820 of 967) with videos related to

Pageof 97
Sort By:
Gynecologic Oncology|September 12, 2020
PD-1 blockade in recurrent or metastatic cervical cancer: Data from cemiplimab phase I expansion cohorts and characterization of PD-L1 expression in cervical cancerDanny Rischin, Marta Gil-Martin, Antonio González-Martin, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|October 8, 2021
[Psychological and behavioral functioning of children and adolescents during long-term home-schooling]L Wang, Y Hao, L Chen, et al.
Gynecologic Oncology|September 18, 2022
Circulating tumor DNA monitoring for early recurrence detection in epithelial ovarian cancerJune Y Hou, Jocelyn S Chapman, Ekaterina Kalashnikova, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2001
SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivoJ M Strizki, S Xu, N E Wagner, et al.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|November 14, 2018
[HER2 status in gastric adenocarcinoma of Chinese: a multicenter study of 40 842 patients]D Huang, Z S Li, X S Fan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 2022
Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy followed by minimally invasive esophagectomy for locally advanced esophageal squamous cell carcinoma: a prospective multicenter randomized clinical trialH Tang, H Wang, Y Fang, et al.
Molecular Psychiatry|April 29, 2015
p75NTR ectodomain is a physiological neuroprotective molecule against amyloid-beta toxicity in the brain of Alzheimer's diseaseX-Q Yao, S-S Jiao, K Saadipour, et al.
The Journal of Clinical Investigation|July 1, 2025
Targeting immune checkpoint LAIR1 with antibody blockade or 3-in-1 CAR T cells enhances antitumor responseHaipeng Tao, Dongjiang Chen, Changlin Yang, et al.
Zhonghua Fu Chan Ke Za Zhi|January 29, 2026
[Efficacy and safety of triptorelin acetate microspheres for injection versus triptorelin acetate for injection in Chinese patients with endometriosis: a multicenter, randomized, double-blind, phase Ⅲ non-inferiority clinical trial]A M Zhao, Y Wang, W W Yang, et al.
Cancer Discovery|April 16, 2023
A Transcriptome-Based Precision Oncology Platform for Patient-Therapy Alignment in a Diverse Set of Treatment-Resistant MalignanciesPrabhjot S Mundi, Filemon S Dela Cruz, Adina Grunn, et al.
Pageof 97

Showing results (811-820 of 967) with videos related to

Sort By:
Pageof 97
Gynecologic Oncology|September 12, 2020
PD-1 blockade in recurrent or metastatic cervical cancer: Data from cemiplimab phase I expansion cohorts and characterization of PD-L1 expression in cervical cancerDanny Rischin, Marta Gil-Martin, Antonio González-Martin, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|October 8, 2021
[Psychological and behavioral functioning of children and adolescents during long-term home-schooling]L Wang, Y Hao, L Chen, et al.
Gynecologic Oncology|September 18, 2022
Circulating tumor DNA monitoring for early recurrence detection in epithelial ovarian cancerJune Y Hou, Jocelyn S Chapman, Ekaterina Kalashnikova, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2001
SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivoJ M Strizki, S Xu, N E Wagner, et al.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|November 14, 2018
[HER2 status in gastric adenocarcinoma of Chinese: a multicenter study of 40 842 patients]D Huang, Z S Li, X S Fan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 2022
Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy followed by minimally invasive esophagectomy for locally advanced esophageal squamous cell carcinoma: a prospective multicenter randomized clinical trialH Tang, H Wang, Y Fang, et al.
Molecular Psychiatry|April 29, 2015
p75NTR ectodomain is a physiological neuroprotective molecule against amyloid-beta toxicity in the brain of Alzheimer's diseaseX-Q Yao, S-S Jiao, K Saadipour, et al.
The Journal of Clinical Investigation|July 1, 2025
Targeting immune checkpoint LAIR1 with antibody blockade or 3-in-1 CAR T cells enhances antitumor responseHaipeng Tao, Dongjiang Chen, Changlin Yang, et al.
Zhonghua Fu Chan Ke Za Zhi|January 29, 2026
[Efficacy and safety of triptorelin acetate microspheres for injection versus triptorelin acetate for injection in Chinese patients with endometriosis: a multicenter, randomized, double-blind, phase Ⅲ non-inferiority clinical trial]A M Zhao, Y Wang, W W Yang, et al.
Cancer Discovery|April 16, 2023
A Transcriptome-Based Precision Oncology Platform for Patient-Therapy Alignment in a Diverse Set of Treatment-Resistant MalignanciesPrabhjot S Mundi, Filemon S Dela Cruz, Adina Grunn, et al.
Pageof 97